Amgen Inc.
AMGNNASDAQHealthcare● Active
$349.58
+$3.98(+1.15%)
Market Cap$188.7B
P/E Ratio—
52W High$391.29
52W Low$267.83
Amgen Inc. (AMGN) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · AMGN · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $36.74B | $33.42B | $28.19B | $26.32B | $25.98B |
| Cost of Revenue | $10.73B | $12.86B | $8.41B | $6.41B | $6.45B |
| Gross Profit | $26.01B | $20.57B | $19.77B | $19.92B | $19.52B |
| Gross Margin %(computed) | 70.80% | 61.53% | 70.15% | 75.66% | 75.16% |
| Operating Expenses | |||||
| R&D Expenses | $6.97B | $5.96B | $4.78B | $4.43B | $6.32B |
| G&A Expenses | $0.00B | $6.11B | $0.00B | $4.57B | $4.53B |
| Total Operating Expenses | $15.34B | $13.31B | $11.84B | $10.35B | $11.89B |
| Operating Income | $10.68B | $7.26B | $7.90B | $9.57B | $7.64B |
| Operating Margin %(computed) | 29.06% | 21.71% | 28.01% | 36.34% | 29.40% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $2.75B | $3.15B | $2.88B | $1.41B | $1.20B |
| Income Before Tax | $8.98B | $4.61B | $7.86B | $7.35B | $6.70B |
| Income Tax Expense | $1.26B | $0.52B | $1.14B | $0.79B | $0.81B |
| Net Income | $7.71B | $4.09B | $6.72B | $6.55B | $5.89B |
| Net Margin %(computed) | 20.99% | 12.24% | 23.83% | 24.89% | 22.68% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $14.33 | $7.62 | $12.56 | $12.18 | $10.34 |
| Wtd Avg Shares | 0.54B | 0.54B | 0.54B | 0.54B | 0.57B |
| EBITDA | $15.84B | $13.36B | $14.80B | $12.17B | $11.30B |
| EBITDA Margin %(computed) | 43.12% | 39.96% | 52.50% | 46.23% | 43.48% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Amgen Inc. data
About Amgen Inc. (AMGN) Income Statement
Amgen Inc. (AMGN) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, AMGN reported revenue of $36.74B, gross profit of $26.01B (gross margin 70.80%), and net income of $7.71B — a net profit margin of 20.99%.
Frequently asked questions
AMGN · 4 questionsAmgen Inc. (AMGN) reported revenue of $36.74B for 2025, up 9.9% year-over-year.
AMGN revenueAMGN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08